Australian Competition and Consumer Commission v Baxter Healthcare Pty Ltd

The Australian Competition and Consumer Commission filed an appeal against Baxter Healthcare Pty Ltd, contending that Baxter had breached the Australian Consumer Law by making false or misleading representations concerning the therapeutic benefits of certain of its products. The case was heard by the Full Federal Court of Australia.

The legal issues the court was required to decide included the interpretation of the Australian Consumer Law, specifically whether Baxter’s representations about the therapeutic benefits of its products constituted false or misleading claims. The court also needed to determine the appropriate procedural steps for handling the appeal, including whether the application to remove the appeal from the list of sittings in Sydney should be dismissed and the allocation of costs.

The court held that the representations made by Baxter were indeed misleading as they did not align with the scientific evidence. The court further determined that the application to remove the appeal from the list of sittings in Sydney should be dismissed, and that the costs of the application should be borne by the appellant, Baxter. This decision was grounded in the procedural fairness and the need to avoid unnecessary delays in the judicial process.

No additional orders were made beyond the dismissal of the application and the allocation of costs. The appeal will proceed as scheduled for the Full Federal Court sittings in February 2006.